Articles published by Centogene NV
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
June 20, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
From Centogene NV
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
May 10, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Receives Nasdaq Non-Compliance Notice
April 02, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
February 29, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
February 28, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Explores Strategic Alternatives
February 28, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Receives French Research Tax Credit Accreditation
January 24, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Announces Preliminary Full Year 2023 Revenue
January 18, 2024
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Announces Voting Results of Extraordinary General Meeting
December 19, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
December 13, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
November 28, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
October 10, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Reports First Half 2023 Financial Results
September 07, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
September 01, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE to Participate in Upcoming Conferences in August
August 07, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
![](https://ml.globenewswire.com/media/9db085f4-b57e-4d19-84cf-62bc960c1d57/small/centogene-logo-png.png)
CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
June 14, 2023
From Centogene NV
Via GlobeNewswire
Tickers
CNTG
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.